NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240108. A total of 8 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $36,568 | – | 32,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,584,000 | $1,774,080 | 0.02% |
| XTX Topco Ltd | 32,650 | $36,568 | 0.00% |
| MEITAV INVESTMENT HOUSE LTD | 40,000 | $44,800 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11,963 | $13,398 | 0.00% |
| MORGAN STANLEY | 1,500 | $1,680 | 0.00% |
| CWM, LLC | 1,000 | $1 | 0.00% |
| Qube Research & Technologies Ltd | 54 | $60 | 0.00% |